Literature DB >> 29671257

Glycogen synthase kinase-3β opens mitochondrial permeability transition pore through mitochondrial hexokinase II dissociation.

Takamitsu Tanaka1, Masao Saotome2, Hideki Katoh1, Terumori Satoh1, Prottoy Hasan1, Hayato Ohtani1, Hiroshi Satoh1, Hideharu Hayashi1, Yuichiro Maekawa1.   

Abstract

Accumulating evidence has revealed pivotal roles of glycogen synthase kinase-3β (GSK3β) inactivation on cardiac protection. Because the precise mechanisms of cardiac protection against ischemia/reperfusion (I/R) injury by GSK3β-inactivation remain elusive, we investigated the relationship between GSK3β-mediated mitochondrial hexokinase II (mitoHK-II; a downstream target of GSK3β) dissociation and mitochondrial permeability transition pore (mPTP) opening. In Langendorff-perfused hearts, GSK3β inactivation by SB216763 improved the left ventricular-developed pressure and retained mitoHK-II binding after I/R. In permeabilized myocytes, GSK3β depolarized mitochondrial membrane potential with accelerated mitochondrial calcein release (suggesting GSK3β-mediated mPTP opening) and decreased mitoHK-II bindings. GSK3β-mediated mPTP opening depended on mitoHK-II binding, i.e., it was accelerated by dissociation of mitoHK-II (dicyclohexylcarbodiimide) and attenuated by enhancement of mitoHK-II binding (dextran). However, inactivation of mitoHK-II by glucose-depletion or glucose-6-phosphate inhibited the GSK3β-mediated mPTP opening. We conclude that GSK3β-mediated mPTP opening may be involved in I/R injury and regulated by mitoHK-II binding and activity.

Entities:  

Keywords:  Glycogen synthase kinase-3β; Ischemia–reperfusion; Mitochondrial hexokinase II; Mitochondrial permeability transition pore

Mesh:

Substances:

Year:  2018        PMID: 29671257     DOI: 10.1007/s12576-018-0611-y

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  22 in total

Review 1.  Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt.

Authors:  R B Robey; N Hay
Journal:  Oncogene       Date:  2006-08-07       Impact factor: 9.867

2.  Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity.

Authors:  John G Pastorino; Jan B Hoek; Nataly Shulga
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

3.  Protein kinase A catalytic subunit alters cardiac mitochondrial redox state and membrane potential via the formation of reactive oxygen species.

Authors:  Shiro Nagasaka; Hideki Katoh; Chun Feng Niu; Saori Matsui; Tsuyoshi Urushida; Hiroshi Satoh; Yasuhide Watanabe; Hideharu Hayashi
Journal:  Circ J       Date:  2007-03       Impact factor: 2.993

4.  The SR/ER-mitochondria calcium crosstalk is regulated by GSK3β during reperfusion injury.

Authors:  L Gomez; P-A Thiebaut; M Paillard; S Ducreux; M Abrial; C Crola Da Silva; A Durand; M R Alam; F Van Coppenolle; S-S Sheu; M Ovize
Journal:  Cell Death Differ       Date:  2015-07-24       Impact factor: 15.828

5.  In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death.

Authors:  Heftsi Azoulay-Zohar; Adrian Israelson; Salah Abu-Hamad; Varda Shoshan-Barmatz
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

6.  GSK3β inhibition and LEF1 upregulation in skeletal muscle following a bout of downhill running.

Authors:  Hiral Amin; Judy Vachris; Alicia Hamilton; Nury Steuerwald; Reuben Howden; Susan Tsivitse Arthur
Journal:  J Physiol Sci       Date:  2013-08-21       Impact factor: 2.781

Review 7.  Regulation of hexokinase binding to VDAC.

Authors:  John G Pastorino; Jan B Hoek
Journal:  J Bioenerg Biomembr       Date:  2008-06       Impact factor: 2.945

8.  Acute PKCdelta inhibition limits ischaemia-reperfusion injury in the aged rat heart: role of GSK-3beta.

Authors:  John C Kostyak; J Craig Hunter; Donna H Korzick
Journal:  Cardiovasc Res       Date:  2006-02-14       Impact factor: 10.787

Review 9.  Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function.

Authors:  John E Wilson
Journal:  J Exp Biol       Date:  2003-06       Impact factor: 3.312

10.  Ischemic preconditioning affects hexokinase activity and HKII in different subcellular compartments throughout cardiac ischemia-reperfusion.

Authors:  Ebru Gürel; Kirsten M Smeele; Otto Eerbeek; Anneke Koeman; Cihan Demirci; Markus W Hollmann; Coert J Zuurbier
Journal:  J Appl Physiol (1985)       Date:  2009-02-19
View more
  7 in total

1.  Hexokinase 1 cellular localization regulates the metabolic fate of glucose.

Authors:  Adam De Jesus; Farnaz Keyhani-Nejad; Carolina M Pusec; Lauren Goodman; Justin A Geier; Joshua S Stoolman; Paulina J Stanczyk; Tivoli Nguyen; Kai Xu; Krishna V Suresh; Yihan Chen; Arianne E Rodriguez; Jason S Shapiro; Hsiang-Chun Chang; Chunlei Chen; Kriti P Shah; Issam Ben-Sahra; Brian T Layden; Navdeep S Chandel; Samuel E Weinberg; Hossein Ardehali
Journal:  Mol Cell       Date:  2022-03-18       Impact factor: 17.970

Review 2.  Molecular mechanisms and consequences of mitochondrial permeability transition.

Authors:  Massimo Bonora; Carlotta Giorgi; Paolo Pinton
Journal:  Nat Rev Mol Cell Biol       Date:  2021-12-08       Impact factor: 113.915

Review 3.  The involvement of protein kinases in the cardioprotective effect of chronic hypoxia.

Authors:  N V Naryzhnaya; H-J Ma; L N Maslov
Journal:  Physiol Res       Date:  2020-11-02       Impact factor: 1.881

Review 4.  Mitochondrial Ion Channels of the Inner Membrane and Their Regulation in Cell Death Signaling.

Authors:  Andrea Urbani; Elena Prosdocimi; Andrea Carrer; Vanessa Checchetto; Ildikò Szabò
Journal:  Front Cell Dev Biol       Date:  2021-01-05

5.  Prostaglandin E1 attenuates post‑cardiac arrest myocardial dysfunction through inhibition of mitochondria‑mediated cardiomyocyte apoptosis.

Authors:  Chenglei Su; Xinhui Fan; Feng Xu; Jiali Wang; Yuguo Chen
Journal:  Mol Med Rep       Date:  2020-12-10       Impact factor: 2.952

6.  Attenuation of hepatic ischemia‑reperfusion injury by adipose stem cell‑derived exosome treatment via ERK1/2 and GSK‑3β signaling pathways.

Authors:  Yaqing Zhang; Yonghua Li; Qilong Wang; Dongyu Zheng; Xue Feng; Wei Zhao; Linlin Cai; Qingqing Zhang; Haitao Xu; Hailong Fu
Journal:  Int J Mol Med       Date:  2021-12-08       Impact factor: 4.101

7.  EP4 activation ameliorates liver ischemia/reperfusion injury via ERK1/2‑GSK3β‑dependent MPTP inhibition.

Authors:  Lin-Lin Cai; Hai-Tao Xu; Qi-Long Wang; Ya-Qing Zhang; Wei Chen; Dong-Yu Zheng; Fang Liu; Hong-Bin Yuan; Yong-Hua Li; Hai-Long Fu
Journal:  Int J Mol Med       Date:  2020-03-17       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.